July 24, 2024

F.D.A. Authorizes a New Covid Drug to Protect High-Risk People

Pemgarda, available in the coming weeks, is intended for immunocompromised people who are unlikely to mount an adequate response after vaccination.Pemgarda, available in the coming weeks, is intended for immunocompromised people who are unlikely to mount an adequate response after vaccination.Read MoreCoronavirus (2019-nCoV), Immune System, Drugs (Pharmaceuticals), Antibodies, TransplantsNYT > Health

Leave a Reply

Your email address will not be published. Required fields are marked *